WARFARIN Safety Questions, WARFARIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about WARFARIN. Our extensive database of WARFARIN adverse events and WARFARIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about WARFARIN
WARFARIN Safety Reports
Total WARFARIN reports: 942.WARFARIN FDA safety alerts: 2001 2002 2004 2006 2007 .
Reported deaths: 135 Reported hospitalizations: 645.
Take WARFARIN Side Effects Survey or Share Your WARFARIN Story. Read More Here.
Showing 1-75 of 942 Next >
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 14, 2007. Male patient, 75 years of age, weighting 216.1 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: faeces discoloured, haematocrit decreased, malaise, occult blood positive. WARFARIN dosage: 2.5MG DAILY PO. During the same period patient was treated with ALLOPURINOL, BUMETANIDE, DIGOXIN, LISINOPRIL, OMEPRAZOLE, VERAPAMIL, NIFEREX. Patient was hospitalized. Patient recovered.WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 14, 2007. Male patient, 75 years of age, weighting 231.5 lb, was diagnosed with cerebrovascular accident and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: anaemia, chest pain, duodenal ulcer, dyspnoea, dyspnoea exertional, faeces discoloured, international normalised ratio increased, upper gastrointestinal haemorrhage. WARFARIN dosage: 10MG/7.5MG T+TH/ROW PO. During the same period patient was treated with ACETAMINOPHEN, AMOXICILLIN, ASPIRIN, FELODIPINE, LEVALBUTEROL, LISINOPRIL, NITROGLYCERIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 14, 2007. Male patient, 78 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: fall, head injury, international normalised ratio decreased, subdural haematoma. WARFARIN dosage: unknown. During the same period patient was treated with ASPIRIN, COUMADIN, DILTIAZEM, FINASTERIDE, INSULIN, ZOCOR. Patient died on 11/26/2006.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 14, 2007. Male patient, 66 years of age, was diagnosed with thrombosis prophylaxis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, international normalised ratio decreased, knee arthroplasty, post procedural haematoma. WARFARIN dosage: 2 MG PO QOD. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN W, DIPHENHYDRAMINE, DOCUSATE NA, FUROSEMIDE, ACETAMINOPHEN AND HYDROCODONE BITARTRATE, METHOCARBAMOL, METHYLCELLULOSE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 14, 2007. Male patient, 54 years of age, was diagnosed with thrombosis prophylaxis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, post procedural drainage. WARFARIN dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, GABAPENTIN, ACETAMINOPHEN AND HYDROCODONE BITARTRATE, QUETIAPINE FUMARATE, WARFARIN NA. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Health Professional from UNITED STATES on Feb 15, 2007. Female patient, weighting 190.0 lb, was diagnosed with aortic valve replacement and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased. WARFARIN dosage: 4MG 6 DAYS PO. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 15, 2007. Male patient, 76 years of age, was diagnosed with mitral valve stenosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal haemorrhage. WARFARIN dosage: 2 MG M-FR 3 MG SAT + SUN. During the same period patient was treated with CITALOPRAM, DIGOXIN, TAMSULOSIN, NITROGLYCERIN, AMIODARONE, FUROSEMIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 12, 2007. Male patient, 61 years of age, weighting 193.6 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gastric ulcer haemorrhage. WARFARIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL, ASPIRIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 12, 2007. Male patient, 62 years of age, weighting 258.8 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: skin haemorrhage. WARFARIN dosage: unknown. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 12, 2007. Male patient, weighting 164.0 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gingival bleeding, international normalised ratio increased. WARFARIN dosage: 5 MG QHS PO. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 12, 2007. Male patient, weighting 151.8 lb, was diagnosed with surgery, infection and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematuria, international normalised ratio increased. WARFARIN dosage: unknown. During the same period patient was treated with CLARITHROMYCIN. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 15, 2007. Male patient, weighting 105.8 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, loss of consciousness, subarachnoid haemorrhage. WARFARIN dosage: 5MG DAILY PO. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 16, 2007. Male patient, 74 years of age, weighting 161.0 lb, was diagnosed with hip fracture and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: constipation, disorientation, epistaxis, fall, femur fracture, gastrointestinal haemorrhage, haematemesis, melaena. WARFARIN dosage: 2.5 MG DAILY PO. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 16, 2007. Male patient, 72 years of age, was diagnosed with surgery and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: epistaxis. WARFARIN dosage: 3.75MG MWF 7.5MG ALL OTHER DAYS. During the same period patient was treated with LISINOPRIL, FELODIPINE, VARDENAFIL, TRAMADOL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 16, 2007. Male patient, 68 years of age, was diagnosed with convulsion and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. WARFARIN dosage: 2.5 MG MON + FRI 5 MG OHTER DAYS. During the same period patient was treated with PHENYTOIN, FUROSEMIDE, DIVALPROEX, GLYBURIDE, TYLENOL W, SERTRALINE, BACLOFEN, METFORMIN. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 16, 2007. Male patient, 65 years of age, was diagnosed with atrial flutter and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. WARFARIN dosage: 5MG QD. During the same period patient was treated with METOPROLOL SUCCINATE, LISINOPRIL, FUROSEMIDE, ZOCOR, ASPIRIN, INSULIN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 16, 2007. Male patient, 44 years of age, was diagnosed with deep vein thrombosis, infection and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemoptysis. WARFARIN dosage: 15 MG M W F + 10 MG OTHER DAYS. During the same period patient was treated with CIPRO, DILANTIN. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 16, 2007. Male patient, 59 years of age, was diagnosed with cardiomyopathy and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haematuria. WARFARIN dosage: 4 MG QD WITH 6 MG MONDAY + THURSDAY. During the same period patient was treated with LOPID, ROSIGLITAZONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from TURKEY reported WARFARIN problem on Jan 30, 2007. Female patient, 52 years of age, was diagnosed with venous thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: vitamin k increased. WARFARIN dosage: unknown. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Male patient, 61 years of age, weighting 198.6 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. WARFARIN dosage: unknown. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 20, 2007. Male patient, 54 years of age, weighting 181.0 lb, was diagnosed with deep vein thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: alcoholism, international normalised ratio increased. WARFARIN dosage: WARFARIN DOSE: 2MG DAILY EXCE PO. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Male patient, 63 years of age, weighting 353.0 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. WARFARIN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported WARFARIN problem on Feb 20, 2007. Male patient, 63 years of age, weighting 218.0 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. WARFARIN dosage: unknown. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 09, 2007. Female patient, 84 years of age, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hypertension, subarachnoid haemorrhage. WARFARIN dosage: unknown. Patient was hospitalized. Patient died on 05/01/2006.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 27, 2007. Male patient, 76 years of age, weighting 209.0 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, ecchymosis, haemoglobin decreased, international normalised ratio decreased, post procedural haemorrhage. WARFARIN dosage: 5 MG QD PO. During the same period patient was treated with ENOXAPARIN. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Feb 27, 2007. Male patient, 83 years of age, weighting 184.3 lb, was diagnosed with deep vein thrombosis, urinary tract infection and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: clostridial infection, deep vein thrombosis, dehydration, delirium, diabetes mellitus, diarrhoea, enterococcal infection, faeces discoloured, fall. WARFARIN dosage: 3 MG QD PO. During the same period patient was treated with AMOXICILLIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported WARFARIN problem on Feb 14, 2007. Female patient, 76 years of age, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: embolic stroke. WARFARIN dosage: unknown. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 13, 2007. Female patient, 71 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: fall, pelvic fracture, retroperitoneal haematoma, vascular injury. WARFARIN dosage: unknown. Patient died.
Pharmacist from UNITED STATES reported WARFARIN problem on Feb 28, 2007. Female patient, weighting 132.3 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: blood urine present, food interaction, international normalised ratio increased, urinary tract infection. WARFARIN dosage: 5 MG M, W, F PO. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Male patient, 49 years of age, weighting 185.0 lb, was diagnosed with heart valve replacement and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: chest discomfort, prothrombin level abnormal. WARFARIN dosage: 5 MG QD ORAL; 2.5 MG, 1/WEEK, ORAL ; 10 MG SINGLE, ORAL. During the same period patient was treated with LEVOTHYROXINE, DIOVAN, VYTORIN, NIASPAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported WARFARIN problem on Feb 28, 2007. Male patient, weighting 178.6 lb, was diagnosed with cerebrovascular accident prophylaxis, thrombosis prophylaxis, hypertension and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: coagulopathy, renal failure, urosepsis. WARFARIN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, LISINOPRIL. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Male patient, 78 years of age, weighting 181.0 lb, was diagnosed with coronary artery disease and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal haemorrhage. WARFARIN dosage: 2 MG ALT WITH 3 MG DAILY. During the same period patient was treated with CRESTOR, LISINOPRIL, FUROSEMIDE, GLIPIZIDE, PROTONIX, AMIODARONE, ASPIRIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported WARFARIN problem on Mar 02, 2007. Female patient, 62 years of age, weighting 150.0 lb, was diagnosed with aortic aneurysm repair and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. WARFARIN dosage: 2 MG/4 MG PO ALTERNATING DAILY. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Female patient, 81 years of age, weighting 155.0 lb, was diagnosed with transient ischaemic attack, blood cholesterol increased and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dizziness, hypoaesthesia, international normalised ratio decreased, transient ischaemic attack, urinary tract infection. WARFARIN dosage: unknown. During the same period patient was treated with ZOCOR, ZESTRIL, MIRTAZAPINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported WARFARIN problem on Feb 16, 2007. Female patient, 69 years of age, weighting 108.9 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, heart rate irregular, international normalised ratio increased, pruritus, urticaria. WARFARIN dosage: 3 MG QD ORAL. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Male patient, 93 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. WARFARIN dosage: unknown. Patient was hospitalized. Patient died on 08/12/2006.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 06, 2007. Male patient, 55 years of age, weighting 145.5 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cardioversion, gingival bleeding, haematemesis, international normalised ratio increased, rectal haemorrhage. WARFARIN dosage: 5MG QD X 9D THEN 2.5 X 2DAY. During the same period patient was treated with AMIODARONE, DIGOXIN, ASPIRIN, LIPITOR, ALLOPURINOL, DIOVAN, ISOSORBIDE. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 06, 2007. Male patient, 68 years of age, weighting 222.0 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: blood urine present, haematochezia, international normalised ratio increased, subdural haematoma. WARFARIN dosage: unknown. During the same period patient was treated with COMBIVENT, MAALOX FAST BLOCKER, PEPCID. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 06, 2007. Male patient, 54 years of age, weighting 142.0 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, haemoglobin decreased, international normalised ratio increased, melaena. WARFARIN dosage: 2.5MG DAILY PO. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 07, 2007. Male patient, 54 years of age, weighting 181.0 lb, was diagnosed with deep vein thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: fall, head injury, international normalised ratio increased, limb injury, pain in extremity, skin haemorrhage. WARFARIN dosage: 2 MG TU/WE/FR/SA/SU, 1MG MO, TH DAILY PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported WARFARIN problem on Mar 08, 2007. Female patient, weighting 170.0 lb, was diagnosed with atrial fibrillation, mitral valve repair, mitral valve replacement and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: impaired healing, international normalised ratio decreased, international normalised ratio increased, onychoclasis, rash erythematous, scar, skin atrophy, skin discolouration. WARFARIN dosage: unknown. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Male patient, weighting 178.6 lb, was diagnosed with cerebrovascular accident prophylaxis, thrombosis prophylaxis, hypertension and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: coagulopathy, renal failure, urosepsis. WARFARIN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, LISINOPRIL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 12, 2007. Male patient, 74 years of age, was diagnosed with deep vein thrombosis, coronary artery disease and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, confusional state, fall. WARFARIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL, ASPIRIN, FOLIC ACID, RANITIDINE, MAGNESIUM OXIDE, CLARITIN, LASIX. Patient was hospitalized. Patient died on 02/18/2007.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 13, 2007. Male patient, 56 years of age, weighting 209.4 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemangioma of liver, haemorrhage. WARFARIN dosage: 5 MG DAILY. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 13, 2007. Male patient, 73 years of age, weighting 374.8 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gastric ulcer, international normalised ratio increased, upper gastrointestinal haemorrhage. WARFARIN dosage: unknown. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from NORWAY on Mar 13, 2007. Female patient, weighting 194.0 lb, was diagnosed with cerebrovascular accident prophylaxis, thrombosis prophylaxis, gout and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, international normalised ratio increased. WARFARIN dosage: unknown. During the same period patient was treated with NAPROXEN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 16, 2007. Male patient, weighting 164.7 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest, hypotension, international normalised ratio increased, upper gastrointestinal haemorrhage. WARFARIN dosage: 5MG DAILY PO. During the same period patient was treated with ASPIRIN, CLINDAMYCIN, GEMFIBROZIL, AMIODARONE. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Male patient was diagnosed with deep vein thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. WARFARIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.
Pharmacist from NEW ZEALAND reported WARFARIN problem on Mar 12, 2007. Male patient, 34 years of age, was diagnosed with atrial fibrillation, hypertension, constipation, schizophrenia and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: colonic pseudo-obstruction, diarrhoea, dyspnoea, fatigue, influenza like illness, intestinal obstruction, lethargy, oedema peripheral, respiratory arrest. WARFARIN dosage: 3 MG NOCTE. During the same period patient was treated with METOPROLOL SUCCINATE, COLOXYL WITH SENNA, KLEAN PREP, CLOZARIL. Patient died on 12/19/2006.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 20, 2007. Male patient, 61 years of age, weighting 140.2 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cough, fatigue, haemoptysis, international normalised ratio decreased, international normalised ratio increased, pharyngolaryngeal pain. WARFARIN dosage: 5 MG DAILY PO. During the same period patient was treated with FONDAPARINUX. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 20, 2007. Female patient, 89 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: burns second degree, burns third degree, international normalised ratio increased. WARFARIN dosage: 4 MG DAILY PO. Patient was hospitalized and became disabled. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 16, 2007. Male patient, weighting 233.9 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal arteriovenous malformation, gastrointestinal haemorrhage, international normalised ratio increased. WARFARIN dosage: 5MG 5X/WK + 2.5MG 2X/WK (PO). During the same period patient was treated with AMOXICILLIN, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 16, 2007. Male patient, weighting 219.4 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: amnesia, cerebral haematoma, lethargy, mental impairment, personality change, physical examination abnormal. WARFARIN dosage: 4 MG DAILY (PO). During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 06, 2007. Male patient, 71 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. WARFARIN dosage: unknown. During the same period patient was treated with GUAIFENESIN, AMIODARONE, DIGOXIN, DOMPERIDONE, LOSARTAN POTASSIUM, MEBEVERINE, OMEPRAZOLE, PAROXETINE. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 21, 2007. Male patient, 58 years of age, weighting 233.7 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: haemoptysis, international normalised ratio increased. WARFARIN dosage: 7.5MG DAILY PO. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 21, 2007. Male patient, 53 years of age, weighting 274.0 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, international normalised ratio increased, renal failure acute. WARFARIN dosage: 10MG QD PO. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 21, 2007. Female patient, 58 years of age, was diagnosed with thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gingival bleeding, international normalised ratio increased. WARFARIN dosage: 5MG DAILY PO. During the same period patient was treated with DURAGESIC, IMITREX, AMBIEN, PERCOCET, LORAZEPAM, ZELNORM. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 21, 2007. Male patient, 77 years of age, weighting 276.7 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: anaemia, international normalised ratio increased, refusal of treatment by patient, upper gastrointestinal haemorrhage. WARFARIN dosage: 10 MG DAILY PO. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported WARFARIN problem on Mar 22, 2007. Female patient, 67 years of age, weighting 160.9 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: contusion, gastrointestinal haemorrhage, haematochezia. WARFARIN dosage: 10MG DAILY PO. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 64 years of age, weighting 173.5 lb, was diagnosed with deep vein thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: faeces discoloured, haematuria, haemoptysis, treatment noncompliance. WARFARIN dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported WARFARIN problem on Mar 22, 2007. Female patient, 75 years of age, weighting 106.9 lb, was diagnosed with atrial fibrillation, cardiac valve prosthesis user and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: asthenia, dizziness, rectal haemorrhage. WARFARIN dosage: 2MG QOD P.O. 1MG QOD P.O.. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 22, 2007. Female patient, 69 years of age, was diagnosed with aortic valve replacement, atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: confusional state, haemorrhage intracranial, international normalised ratio increased, nausea, vomiting. WARFARIN dosage: unknown. During the same period patient was treated with ASPIRIN, FAMOTIDINE, SIMVASTATIN, FOLIC ACID, LEVOXYL, AMIODARONE. Patient was hospitalized. Patient died on 03/13/2007.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 22, 2007. Male patient, 64 years of age, was diagnosed with pulmonary embolism and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: arterial rupture, epistaxis, haemorrhage. WARFARIN dosage: 7.5MG OTHER PO. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 22, 2007. Male patient, 76 years of age, was diagnosed with deep vein thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: epistaxis. WARFARIN dosage: MG EVERY DAY PO. During the same period patient was treated with CLOPIDOGREL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 22, 2007. Male patient, 67 years of age, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, post procedural complication. WARFARIN dosage: 5 MG EVERY DAY PO. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 22, 2007. Male patient, 75 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, rectal haemorrhage. WARFARIN dosage: MG EVERY DAY PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CANADA reported WARFARIN problem on Mar 09, 2007. Male patient, 77 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, condition aggravated, conjunctival haemorrhage, dyspnoea, fatigue, haemoglobin decreased, international normalised ratio increased. WARFARIN dosage: unknown. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 27, 2007. Male patient, 75 years of age, weighting 201.0 lb, was diagnosed with atrial fibrillation, bronchitis, chronic obstructive pulmonary disease and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: contusion, haematoma, necrosis, swelling. WARFARIN dosage: 3 MG DAILY PO. During the same period patient was treated with MOXIFLOXACIN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 27, 2007. Male patient, 76 years of age, weighting 167.0 lb, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, gingival bleeding. WARFARIN dosage: 5 MG DAILY PO. During the same period patient was treated with LOVENOX, GABAPENTIN, LISINOPRIL, METOPROLOL SUCCINATE, OMEPRAZOLE, OXYCODONE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 27, 2007. Male patient, 82 years of age, weighting 147.0 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: lower gastrointestinal haemorrhage, weight decreased. WARFARIN dosage: 4 MG DAILY PO. During the same period patient was treated with DOCUSATE NA, TAMSULOSIN, INDOMETHACIN, ALLOPRUINOL, SIMVASTATIN, TRAZODONE, LEVETRIACETAM, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 27, 2007. Male patient, 82 years of age, weighting 147.0 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, haematochezia, lower gastrointestinal haemorrhage, weight decreased. WARFARIN dosage: 4 MG DAILY PO. During the same period patient was treated with DOCUSATE NA, TAMSULOSIN, INDOMETHACIN, ALLOPURINOL, SIMVASTATIN, TRAZODONE, LEVETRIACETAM, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 14, 2007. Female patient, 85 years of age, weighting 99.21 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: contraindication to medical treatment, haematoma, mobility decreased, pain. WARFARIN dosage: unknown. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE, COMBIVENT, DIGOXIN, FUROSEMIDE, LACTULOSE, ACETAMINOPHEN, RAMIPRIL, SENNA. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 29, 2007. Male patient, 64 years of age, weighting 163.0 lb, was diagnosed with deep vein thrombosis and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, asthenia, dysuria, international normalised ratio increased, lethargy, prothrombin time prolonged. WARFARIN dosage: 5 MG DAILY PO. During the same period patient was treated with OXYCODONE, METFORMIN, LOPERAMIDE, TEMAZEPAM, AMITRIPTYLINE, ATENOLOL, FERROUS SULPHATE, GABAPENTIN. Patient was hospitalized. Patient recovered.
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Mar 29, 2007. Male patient, 61 years of age, was diagnosed with heart valve replacement, pain and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: dizziness, haematocrit decreased, international normalised ratio increased, melaena. WARFARIN dosage: 3.75 DAILY, EXC. 7.5MG ON WED DAILY PO. During the same period patient was treated with NAPROXEN, ACETAMINOPHEN, ASPIRIN, CARVEDILOL, DIGOXIN, ENALAPRIL MALEATE, FOLIC ACID, INSULIN REGULAR. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported WARFARIN problem on Mar 28, 2007. Male patient, 74 years of age, weighting 272.0 lb, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: blood urine present, dysphasia, haematuria, memory impairment, treatment noncompliance. WARFARIN dosage: 10 MG DAILY PO. During the same period patient was treated with ATENOLOL, CYANOCOBALAMIN, FUROSEMIDE, GLYBURIDE, LISINOPRIL, ROSIGLITAZONE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Showing 1-75 of 942 Next >
This
drug has an active FDA Safety Alert